Acuta Capital Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-77
| Closed | -$248K | – | 46 |
|
|
2022
Q1 | $248K | Sell |
77
-574
| -88% | -$1.85M | 0.12% | 36 |
|
|
2021
Q4 | $4.08M | Sell |
651
-94
| -13% | -$588K | 1.71% | 20 |
|
|
2021
Q3 | $6.89M | Hold |
745
| – | – | 2.43% | 12 |
|
|
2021
Q2 | $7.55M | Buy |
745
+297
| +66% | +$3.01M | 3.02% | 9 |
|
|
2021
Q1 | $8.58M | Buy |
+448
| New | +$8.58M | 3.09% | 10 |
|